Read about the recent acquisition of Mentor Planning & Consulting here.
Since 1993, Mentor has provided travel and meetings management consulting and planning services to clients in the pharmaceutical, medical, financial, legal, engineering, consumer products and high tech sectors. In 2005, Mentor established a pharmaceutical consulting division that continues to focus on Phase 2 and Phase 3 clinical trials, as well as KOL development within a number of therapeutic areas.
Mentor has developed a niche in supporting pharmaceutical and medical technology clients focused on Pulmonary Hypertension (PAH, CTEPH), Neurology (Parkinson’s, Alzheimer’s, Schizophrenia, Dementia and Depression) and Infectious Diseases (HIV/AIDS, Hepatitis, C. difficile), but has also worked in a number of other therapeutic areas, including:
Mentor has built an outstanding reputation for integrity in dealing with clients and vendor partners, an unparalleled attention to detail, personalized “high-touch” service in all dealings, and innovative solutions that offer measurable results.
Mentor combines expert knowledge, unsurpassed attention to detail and vast industry resources to flawlessly execute events on behalf of our clients.
Mentor partners with clients to develop and execute effective and compliant clinical trial and brand strategies on time and within budget.
Pulmonary Hypertension, Infectious Diseases, Neurology, Hematology, Ophthalmology, Nephrology, Gastroenterology, Oncology
Mentor CME specializes in producing live and enduring CME activities in partnership with top tier ACCME-accredited educational institutions.
"Mindy and the team at Mentor have provided expertise and unique insights that I have not seen from any other consultants in our work with clinical experts, advisory boards and highly influential opinion leaders. Their contribution goes well beyond supporting our efforts in building relationships and planning for clinical studies. They have enabled us to move faster, avoid pitfalls and build critical relationships with some of the most important clinical leaders in the world."
Vincent Aurentz - Pharma EVP & Chief Business Officer
"…superb at discerning a client's wishes and needs prior to the client even knowing that they have the need…engaged in creating a perfect meeting, and to making sure it's perfect along the way…the execution that takes your meeting to a higher level, surpassing expectations."
Rob Etherington - Pharma CEO
"Your [annual medical] symposium is simply in a class by itself. That applies to the quality of the science, the opportunities for interchange, the nicely balanced “fun” relief and the extraordinary faculty and on-site management. There simply is no comparable conference and it seems to keep getting better each year."
John Bartlett, MD - Professor of Medicine Emeritus / Johns Hopkins University School of Medicine
Roseland, NJ – January 1, 2020 – The Westfield Group today announced the recent acquisition of Mentor Planning & Consulting, Inc. Under the agreement, The Westfield Group has acquired Mentor’s assets, people and customer contracts. The business will operate as a separate division within The Westfield Group brand. Mindy Cimmino, the Founder and President of Mentor, will continue to maintain her role as President of Mentor. As a privately held company, the terms of the deal are not disclosed.
“This acquisition offers an exciting opportunity for The Westfield Group to provide additional services and specialized support for our valued clients from the initial stages of product development right through a product launch and commercialization,” explains Tony Cherichella, Managing Partner of The Westfield Group. “The acquisition of Mentor supports our ongoing strategy to offer the most robust portfolio of end-to-end services – from early stage clinical development to strategic consulting and medical communications to new product launches, speaker programs and full meeting logistics support.
“The Westfield Group has a long, successful operating history similar to Mentor and offers our clients and team members access to an enhanced infrastructure and resources I was intentionally and thoughtfully seeking in order to accommodate the significant growth in demand we have been experiencing year over year. Mentor’s areas of expertise are complementary to those of The Westfield Group and we are aligned in our mission,” added Mindy Cimmino, Founder & President of Mentor. “I am delighted to be joining such a dedicated and forward-looking firm. We now have the combined capability to support our valued clients through the entire product life cycle from drug development to market launch and beyond, with the ultimate goal of positively impacting the lives of patients who may benefit from new or improved therapeutic options.”
The Westfield Group is a full-service medical communications and meetings and events provider focusing largely in the pharmaceuticals, biotech and life sciences industries. With a customer-centric business approach, a collaborative mindset, and years of specialized experience, we approach each project by challenging conventional thinking to ensure every engagement is exceptional. We believe that when we focus on the smallest of details, we achieve the biggest results. For more information about both The Westfield Group and Mentor Planning & Consulting, visit www.wgusa.com.
Mentor succeeds by exceeding the expectations of our internal associates, our partners and our clients. We strive to create an environment where all associates are valued and respected, and where pride in doing it the “right way” takes precedent over doing it the “easy way.” We aspire to continually set the standard for excellence in service while evolving and redefining this standard via new technologies, personal passion and commitment, and collaboration with our partners, clients and our internal team. We understand that our business and success are built and sustained upon a foundation of unwavering integrity, honest business practices, a steadfast commitment to our team and outstanding service to our clients.